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to enable ’direct to patient’ enrolment into
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Background: Difficulties with recruitment pose a major, increasingly recognised challenge to the viability of
research. We sought to explore whether a register of volunteers interested in research participation, with data
linkage to electronic health records to identify suitable research participants, would prove acceptable to healthcare
staff, patients and researchers.
Methods: We undertook a qualitative study in which a maximum variation sampling approach was adopted. Focus
groups and interviews were conducted with patients, general practitioners (GP), practice managers and health
service researchers in two Scottish health boards. Analysis was primarily thematic to identify a range of issues and
concerns for all stakeholder groups.
Results: The concept of a national research register was, in general, acceptable to all stakeholder groups and was
widely regarded as beneficial for research and for society. Patients, however, highlighted a number of conditions
which should be met in the design of a register to expedite confidence and facilitate recruitment. They also gave
their perceptions on how a register should operate and be promoted, favouring a range of media. GPs and practice
managers were primarily concerned with the security and confidentiality of patient data and the impact a register
may have on their workload. Researchers were supportive of the initiative seeing advantages in more rapid access
to a wider pool of patients. They did raise concerns that GPs may be able to block access to personal patient data
held in general practice clinical systems and that the register may not be representative of the whole population.
Conclusions: This work suggests that patients, healthcare staff and researchers have a favourable view of the
potential benefits of a national register to identify people who are potentially eligible and willing to participate in
health related research. It has highlighted a number of issues for the developers to incorporate in the design of
research registers.
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Between 30-50% of all randomised controlled trials fail
to recruit a sufficient number of participants [1]. In a
speech on 5th December 2011, the United Kingdom’s
(UK) Prime Minister proposed two main changes to the
use of data collected in the National Health Service
(NHS) in an attempt to address this issue [2]. Firstly, he
advocated a public consultation on changing the NHS
constitution to enable all patient data to be “automatic-
ally included in clinical research” with an opt-out for
those who did not wish to participate; and secondly, a
mechanism to provide researchers access to NHS re-
cords to identify and directly contact patients who might
qualify for clinical trials. There is now a widely accepted
realisation that the ability to conduct clinical research is
threatened in the UK. Similar concerns are also being
expressed in many other countries [3,4].
Other strategies to improve recruitment of participants
to trials have recently been assessed in a Cochrane re-
view, but with the exception of telephone reminders and
opt-out strategies, most were found to be of limited
value [5]. An alternative approach is the creation of a
register of patients who have expressed a general interest
to participate in research. Such an approach may entail
registrants volunteering information about their health
or patients giving permission for research teams to
search their electronic health records (EHRs) to assess
whether they met the eligibility criteria for studies. If so,
they could then be informed about relevant studies and
offered the chance to participate. Volunteer research
registers already exist, varying in terms of disease [6,7],
study type [8], and location such as the pioneering ‘Vol-
unteer for Vanderbilt’ system [9]. Registrants are notified
electronically when they are a possible match to a pro-
posed research project and they then make the decision
regarding the release of their contact information. The
Vanderbilt approach is now being adopted nationally in
the United States of America (USA) as part of the new
US Research Match program, which comprises a con-
sortium of institutions under the aegis of the National
Institutes of Health (NIH) [10]. These registers ensure
that personal information is protected until volunteers
authorize the release of their contact information to a
specific study. MediGuard is another system which pro-
vides a free medication monitoring service and enables
its 2.5 million registrants to be contacted directly about
research for which they may be eligible [11]. In Scotland,
the unique Community Health Index (CHI) has allowed
deterministic record linkage of health data since the
1970s. This has enabled the development of exceptional
data resources and long tradition of excellence in eHealth
informatics research recognized by a leading role in the
UK’s network of health eResearch centres funded by
the MRC and a consortium of other funders: the FarrInstitute [12]. The Diabetes Research Register in Scotland
has already shown that response rates are likely to be
higher, significantly faster and with fewer screen failures
amongst patients who have previously considered and
expressed interest in participation and whose electronic
records (EHRs) are used to identify their suitability for
studies, than the general population [13].
Given the increasing adoption of EHR systems in
the UK, we believe there is a considerable opportunity
to use the data within EHRs to identify people for re-
search projects though the risks of doing so need to
be addressed [14-16]. The proposed model was de-
veloped following national discussions with a range of
key stakeholders, including the British Medical As-
sociation (BMA), research charities, patient repre-
sentative groups, the pharmaceutical industry and the
Scottish Government [17]. Instead of self-reported
health data, we proposed using clinical data in med-
ical records and linked information in laboratory and
administrative databases across Scotland [18].A national research register - proposed process model
Briefly, the technology now exists to extract data from
various EHRs (primary care, dental, hospital records
and many more) and link this information via the pa-
tient’s CHI number. Data linkage makes it possible to
identify patients who may be eligible for studies based
on data held in their EHRs. The proposed register
model only holds registration and contact preference
data on patients; when linked to eHealth records it en-
ables the identification of potentially eligible patients
for studies Figure 1.
Patients either register via the website or completing
their details on a form for secure entry by register staff.
In doing so, they are providing consent for to their EHRs
to be securely searched within the NHS to assess
whether they met the eligibility criteria for studies which
have NHS ethical and governance approval.
Researchers contact the register administrators with
their inclusion and exclusion criteria, and if all the ap-
propriate approvals were in place, an electronic search is
carried out to identify eligible patients. Patients are in-
formed by register staff about relevant studies and of-
fered the chance to participate and if interested respond
directly to the researcher.Aim
In the context of developing the system specification, we
sought to explore the acceptability and feasibility of the
national research register model to patients, clinicians,
healthcare management staff and researchers to under-
stand their perspectives on key facilitators and barriers
to engagement.
Figure 1 (See legend on next page.)
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Figure 1 An example of how a research study enquiry will be processed by the proposed research register. An enquiry will be received
and checked by register staff for eligibility. Once eligibility is determined search criteria will be generated and a search will be run on all relevant
databases for matching Community Health Index (CHI) numbers. These databases will include the Scottish Morbidity Records (SMR), GP records
and laboratory data to name a few. This search will generate a list of research interested patients with eligibility criteria for the study in question.
The register staff will check if any of these people have recently been contacted about another study. If available the patient will be contacted
and willingness to participate will be explored. If they say no the register will be updated and if they say yes, the researchers will be given the
patients contact information and the register will be updated.
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Focus groups and semi-structured interviews were
conducted between February and June 2011 with pa-
tients, general practice staff from NHS Tayside and
NHS Lothian and academic researchers from the local
University. Focus groups were chosen for patients as
the concept of a research register would be novel and
focus groups present an efficient way to demonstrate
new ideas, allow people to use the responses of others
as a starting point, and are especially helpful in under-
standing nuances of attitudes, beliefs, or opinions. In-
terviews were considered more efficient for health
service staff that have difficulty attending focus
groups. This study was approved by the Tayside Com-
mittee on Medical Research Ethics B, (reference num-
ber: 11/S1402/6) and written informed consent was
obtained from all participants.
Sampling and recruitment
Research interested general practices in two Scottish
health boards were identified via the Scottish Primary
Care Research Network [19].
General practices: General practitioners (GPs) and
practice managers from 10 practices were invited to take
part in telephone semi-structured interviews. This was a
purposive, convenience sample to gain perspectives from
clinically active GPs who act as data controllers.
Patients
We aimed to recruit a maximum variation sample of
ages, rurality, sex and deprivation, via the participating
general practices. 732 patients from five practices were
invited to attend focus groups by their general practice
on behalf of the research team. No reminder letters were
sent.
In addition, focus groups were organised with admin-
istrative members of staff from the local hospital and
university to gain a wider patient perspective.
A focus group was also held with members of the local
Public Patient Partnership group (PPG).
Research staff
Health service researchers and data analysts from the
University of Dundee were invited to take part in a
focus group. Participants were purposively selectedwith experience in data-linkage and recruitment to
clinical studies.
Data generation
The focus groups and interviews sought to establish if
the proposed model was acceptable to key stakeholders
and to gain an understanding of their perspectives on
how the register should operate and be advertised; to in-
form the design, development, operationalisation and
promotion of a national research register.
Prior to every focus group and interview, the facilitator
gave a short presentation as to the current problems
with patient recruitment to research and how a national
research register was expected to work, including infor-
mation about possible mechanisms for participation and
data extraction and linkage mechanisms. These discus-
sions were further facilitated by a topic guide as an aide
memoire, audio-recorded and transcribed verbatim. The
topic guides and presentations were modified between
focus groups and interviews. Focus groups with patients
and researchers lasted approximately an hour. Focus
groups with patients were held in local health centres
and with researchers within the University department.
Telephone interviews with GPs and practice managers
lasted for approximately half an hour.
Data analysis
Focus groups and interviews were conducted by two so-
cial science researchers (AG & DN) and the focus
groups were supported by a rapporteur responsible for
writing notes and capturing key points. All the audio-
recordings were transcribed verbatim. The transcripts
were read and re-read by three of the researchers inde-
pendently (DN, JU & AG). An initial coding frame was
developed inductively from the interviews, and disagree-
ments were discussed and resolved. This was then sys-
tematically applied to all transcripts. Themes were
organised under related concepts derived from the topic
guide and thematic analysis. The data was explored for
negative cases [20,21].
Results/findings
A total of 17 general practitioners and practice managers
were interviewed, 37 people took part in seven patient
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in another focus group.Patient perspectives of a national research register
The following findings are from the seven focus groups
held with patients.Acceptability of a research register
The focus group discussions were generally positive to-
wards the concept of a research register. Participants in
the patient focus groups could understand the aims and
rationale for the register and made reference to the ben-
efits as being for the ‘common good’ and to advance
research:
“….. I mean it’s a better system than it is at the present,
because you are going to get 100% response that way or
near enough and the present system is that the GPs put
out things on spec to people that may want to join this
thing and they may get a very low return” (Male,
patient focus group 3, PPG).
And:
“..the great advantage of a system like this is that if I
was a researcher dealing with a rare disease and I
wanted to get together everybody in the country, or
perhaps all five of them for instance to do some trial on
them, I could identify these people” (Male, patient focus
group 2).
There was a willingness to participate in the register,
with the vast majority of the patient participants indicat-
ing they would be likely to join the national research
register, in principle:
“Well I think it’s a good thing to get involved in
(referring to a national research register), I just felt that
I wanted to do it and…quite happy….to see what
happens now, as you say I can withdraw if I’m
unhappy, if I’m happy I’ll just stay in….” (Female,
patient focus group 4).
And:
“…research register seems like a great idea, why has
nobody done it before?” (Female, patient focus group 6)
The remaining participants felt they required more in-
formation about how the research register would oper-
ate, including recruitment and management processes
(these issues are addressed below).“…I’m here to find out a little bit more about it, I don’t
know enough at the moment. And I also think pre-
authorising people to access my data might be an issue.
I don’t know what sort of studies you’re doing” (Male,
patient focus group 3, PPG).
Although most patients perceived the register to be
for the ‘common good’, those who said they were likely
to register indicated that their rationale for registering
would be primarily personal with the hope of future
health gains for themselves or their family, so would be
interested in contributing to research in areas of concern
to them.
“…I’ve got arthritis in my spine and if there’s something
new or something that can help wi the pain I have,
which is not constant then I’d be willing to try anything
cause when it’s bad, it’s bad.” (Female, patient focus
group 1.).
Some participants did provide a more altruistic ration-
ale for registering.
“…I’ve been, had quite a few things done under the NHS
the past two or three years so I’m quite happy to put
things back” (Male, patient focus group 3, PPG).
Our data show that the concept of a research register
is acceptable to patients who volunteer for research via
invitation from their GP practice. We do not suggest
that all patient groups would be likely to enroll with a
research register but these findings suggest that a re-
search register is likely to recruit patients who wish to
give a ‘gift’ to society or who wish to contribute for per-
sonal gain. Doubts have been expressed about the ability
of biobanks to deliver on ‘promises’ [22]. It is not the
intention of a national research register to make any
claims about enrolment and participation in research
leading to improvements in health care prevention, diag-
nosis or treatment regimens which may give patients
false hope.
What would expedite confidence to facilitate recruitment
to a national research register?
The participants of the patient focus groups identified a
number of conditions which they felt should be met in
the design of a national research register and website to
encourage confidence and facilitate recruitment:
Information about the kind of personal data extracted from
patient records
Some participants wanted more information about the
nature of personal data which would be extracted from
patient records. They had reservations about more
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illustrates:
“Yeah and what would be, the factual information that
goes into this Register, you know in terms of actually the
factual information that goes there, for instance thinking
about mental health and thinking about, you know
things, or disclosure or sexual abuse or, all these kind of
things …” (Female, patient focus group 4).
Some focus group participants expressed the view that
that people might not wish to participate in studies
about sensitive issues. Designers of the research register
also considered that people may not be aware or may
have forgotten their health care record contains sensitive
information and access to certain information could
make registrants vulnerable. Based on these observations
sensitive information would not be accessed by re-
searchers without explicit patient consent. On occasions
where researchers might want access to information
such as mental or sexual health they would only be pro-
vided with anonymised data within the strict ethics and
governance rules and regulations which are in place to
protect vulnerable patients in accordance with the pro-
portionate governance arrangements of the Scottish
Health Informatics Programme (SHIP) [23].
Concerns about data security
All participants wanted reassurance their data was to be
handled securely. Participants recruited via the local
University and NHS hospital were already informed of
some of the governance and legislative issues involved in
handling confidential patient data.
“… if you don’t think your data’s secure then it's really,
really going to, to put a lot of people off, you know, it
just takes one slip up in that department and that’s just
going to completely put people off from signing up”
(Female, patient focus group 6).
And
“..reassurance…it would just be few hands and eyes … so
it's not being passed around” (Male, patient focus group
6).
Whereas, participants recruited via general practices
assumed the electronic transfer information within the
NHS was already taking place and some assumed politi-
cians had access:
“…I don’t mind where my data goes…I just wondered
when and where and who was doing this. Was it
Scottish Government or the NHS and where do yourrecords sit? Because I would like my records to be
available throughout the country, I don’t care once
they’re on the internet and a doctor here can call
them up, but I’m totally surprised how if you
move from one practice to another your records
can’t now electronically move easily.” (Male, patient
focus group 1)
And
“Does Alex Salmond’s (Scotland’s first minister)
department and does Shona Robinson from Dundee, as
health minister in Scotland, are they not already
looking at these figures and data?”(Male, patient focus
group 2)
All participants were informed of the research ethics,
governance and legal frameworks within which re-
search teams and the operators of the research register
are accountable. Patients were reassured by this and
felt this information should be made available on the
register website, along with how particular studies were
approved or included in the register:
”…I understand, I understand, I am a lot more
enlightened”, (male)
“That information should be made available for people”
(female) (Patient focus group 2).
And
“One of the things I’d like to see is that there was a sign
off on adequate training on all the legislative
requirements for holding people’s data…you know if
you’re going to minimise risk then everybody has to
know absolutely where the legislation lies..” (Female,
patient focus group 1).
Although participants were concerned about the sen-
sitivity of some data and the security of all data and
were reassured by governance and legislative controls it
was difficult to ascertain their views about these issues
in relation to data extraction and linkage. Specific con-
cerns were not raised and questions were not clearly
responded too.
Reassurance about levels of commitment involved in the
register
Despite understanding the rationale behind the register
and being willing to register participants were ambiva-
lent about making open-ended commitments. Some par-
ticipants argued that registrants may not always be able
to contribute to research or only to studies with minimal
involvement.
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what people would be asking me - would it be lots of
projects?” (Female, patient focus group 6)
And
“Yeah, I suppose it just depends what’s like going on in
your life at the time, you know how busy you are with
other things.” (Female, patient focus group 5)
Or
“…probably ones that take up the least of your time,
'cause if you've to keep going to the surgery or go
somewhere to do things, if you get a questionnaire in the
post, I'd quite happily fill that in and post it back”
(Female, patient focus group 1)
During the focus group discussions participants were
asked how often they thought registrants should be
contacted to participate in research studies.
“..I don’t know perhaps if I was being asked to do
something every week I might think that’s a bit much,
but if it was may be once every six months I would
think that was alright, once a year, that’s alright…it just
depends… (Female, patient focus group 3, PPG)
There was no consensus about frequency of contact
because the research studies which will hopefully utilise
a research register will have differing levels of involve-
ment. Participants felt reassured that they could have
options to refuse to participate in a study which would
be easy to complete and not time consuming and oppor-
tunities to withdraw if their circumstances change.
“I mean sometimes you go into these things thinking
that’s fine….it’s only an hour a month or whatever but
sometimes life doesn’t give you that opportunity”
(Female, patient focus group 2).
Of more concern was that participation in one study
may prevent them from taking part in another:
“…if you’re taking part in a longitudinal study, as I
have done in the past, and it’s just a question of, it’s just
a kind of questionnaire about my diet and that kind of
thing, would that prevent me from taking part in
something else?” (Female, patient focus group 3)
This raises questions about how participation in a na-
tional register may be ethically monitored. Some studies
may involve participation in a ‘one-off ’ interview or
questionnaire study whereas other studies may requiremore intensive participation. Suggestions by researchers
designing the register to resolve this issue have centred
on a maximum of three invitations per year.
This section has raised some important concerns
around sensitive information, data security and levels of
involvement. These concerns raise the issue of who
should be in control of a national research register.
Patient perceptions of how a national research register
should operate
The focus groups also set out to understand patient per-
ceptions of how a national research register should oper-
ate, exploring issues such as ownership and control of
the registers and the involvement of pharmaceutical
companies.
Who should host a national research register?
All participants placed trust in Universities and the NHS
as potential organisations to host a national research
register, indicating they would prefer public ownership.
“…but government, Universities, charities, I would’nae
have a problem if they were behind it but I think the
drug companies, I would step back from that” (Female,
patient focus group 6).
Within these public organisations patients would pre-
fer access to their data to be controlled:
“I would like, like as little people as possible, you know I
don’t want every NHS staff to be able to access it, I
would want core (national register proposed name)
registered people, you know not even researcher, I
wouldn’t want them to be able to access it, I would
want them to be able to go to somebody who was in
charge of the database to be able to give them the
information out, I wouldn’t want a lot.” (Female, patient
focus group 5)
It was important for the patient focus group partici-
pants that a national research register was to be publi-
cally owned and controlled by public servants. One of
the main reasons these participants gave for an intention
to register was for the common good, so they perceived
the register to be a public service and that benefits
should be publically based.
Access to a national research register
Discussions about the register primarily focused on
the implicit assumption that access would be by med-
ical personnel and academics and research scientists
employed by Universities. Participants had particular
concerns about access by insurance companies largely
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refuse to pay out on insurance claims.
“I’m not sure if anyone’s investigated the potential
implications of anyone with a life insurance policy
joining something like this and whether that voids,
invalidates or causes any effect on their insurance given
that they can be particularly funny when it comes to
claims later in life…” (Male, patient focus group 4)
Participants had polarised views towards the poten-
tial involvement of pharmaceutical companies. They
perceived involvement to be in the funding of the regis-
ter or in the funding of particular studies recruiting
through the register. The majority felt the involvement
of pharmaceutical companies in the infrastructure of
the register would put them off registering whereas
others felt the involvement of these companies would
help investment.
“I can see how that would attract the pharmaceutical
companies to invest (in the register) if there was this
spin off effect….an economic benefit” (Male, patient
focus group 2).
And
“I would be slightly more concerned if they went out
wider commercially, say Glaxo-Klein or whatever got
data as part of the research register” (Male, patient
focus group 1). Concern was focused on how ethical
pharmaceutical companies would be “…drugs
company… they always have a vested interest in the
outcome don’t they really?” (Female, patient focus
group 3, PPG)
For some involvement of pharmaceutical companies in
finding research was a necessary evil: “…the drug com-
panies are just trying to make money, and yes of course
they are, it’s all about money in the end of the day but if
they don’t find the research for some of these the less in-
teresting or less topical things then they, there will not be
research into those things…we need to get funding from
drug companies anyway, if they’re the ones with the
money.” (Female, patient focus group 3, PPG)
The involvement of pharmaceutical companies was
controversial and investment by pharmaceutical com-
panies in the infrastructure of the register is likely to
influence registration. A large part of making wider
health benefits a reality, such as those desired by the
focus group participants (improvements in prevention,
diagnosis, and treatment), will require the funding of
pharmaceutical companies. This concern has ensured
that when patients are invited to participate in aresearch study they will be informed of the funding
body. This is likely to result in the register requiring a
larger number of registrants for commercial than pub-
lically funded studies.
The promotion of a national research register
There was a general feeling across all the focus groups
that a national research register would require both local
and national promotion as a public good. They perceived
that the register’s success would depend upon public
awareness, and on highlighting the benefits of taking
part in research and the contribution to society. In the
general practice recruited focus groups this topic was
returned to more than once.
“…personally I think this register should be sold as the
benefit to all of us from birth to death…but I believe
that if you start it now you have to catch the attention
of the young kids to have this evolve through 50 years…”
(Male, patient focus group 2).
They favoured promotion by a range of media:
“Well it depends if I had the budget or if I had other
mechanisms, if budget was no object the television’s
obviously a great mechanism” (Female, patient focus
group 4).
And
“…it would be something that could be advertised to
everyone, like say on the television or you would hear it
on the radio so you know that it’s not something, you
know secretive about, a secret project, it’s about
something that everybody could join in.” (Female,
patient focus group 5)
Or
“I guess information leaflets through you know the door
I guess, you know that would get to the (health board
named) population…I’m not so keen on emails but
certainly something through the mail is always good or,
you know posters up around the hospital or in the GP
surgery…” (Female, patient focus group 6)
There was consensus among all participants, if pa-
tients were to be written to and invited to participate in
the research register this should be by their general
practitioner (GP):
“I do think it (a letter) would be better coming from
their GP” (female)
“GP, Yeah” (female)
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GP because it’s someone that they know, trust in….you’d
just treat it like every other thing and probably just
discard it.” (female) (Patient focus group 1)
There was however a lack of agreement amongst pa-
tient focus group participants as to the best way to pro-
mote a national research register. Some participants
were strongly in favour of invitations coming from
their GP. As recruitment to research via general prac-
tices is increasingly becoming more difficult with the
additional pressures on GP time, these findings suggest
a range of media would be appropriate to appeal to
cross sections of society.Invitations to join research study
Participants were asked how they thought registrants
should be invited to participate in research studies and
there was agreement invitations should initially come
from the research register:
“Well, I think if initially you’ve signed up to this through
a letter from your GP….I, to get the invitation for the
study, that’s when I think it should come from SHARE
(research register)”( Female, patient focus group 6).
And
“That would be fine for me, cause I know that I’ve
signed up for that so I would, you know, you would
expect something to come through at some point” (Male,
patient focus group 2).
There was a real sense in the patient focus groups
that a national research register should be perceived
and promoted as a public good, which should be in
public ownership and operated by public servants.
The involvement of pharmaceutical companies was
contentious, with some participants perceiving their
involvement in funding research studies as a ‘neces-
sary evil’. The appeal of the register as a public good
was thought to be important for inclusion in any ad-
vertising, highlighting registration as contributing to
the good of society.Perspective of practice managers and general
practitioners of a national research register
The general practitioners and practice managers in-
terviewed were generally in favour of a national re-
search register; they however expressed concerns
over the security and confidentiality of personal pa-
tient data and the impact a register would have on
their workload.Acceptability of a research register
All GPs and practice managers interviewed could under-
stand the rationale for a national research register, were
aware of recruitment issues and were in favour of a re-
search register, in principle.
“..in principle it sounds like a good idea, I mean
obviously research is very important and it's difficult to
get people for research.” (Female GP interview 5)
Security and confidentiality of patient data
Of primary concern to all GPs and some practice man-
agers was the security and confidentiality of patient data
within a national research register.
“I think being reassured about the security of the patient
data would be sort of, you know 1A on the, on the list of
things that we need to, to be absolutely 100% eh
reassured by before we could … agree to getting
involved.” (Male GP interview 6)
And
“I mean from our point of view confidentiality is one
of the kind of absolute … you need to be so careful
about if you're giving letters about patients, there's
no third party references and secure e-mails and all
that - so you're thinking “where do we stand with the
law?” … I, I guess you'd have to set it up in such a
way that the patient was fully aware of what they
were signing up to including what data would be
accessed and how it would be accessed and with
whom it would be shared.” (Female GP Interview 1)
And
“I'm not an IT expert but it just feels like the more
people there are who have access potentially to
patients’ records, the more chance there is that
there’ll be, it, confidential information leaked and I
mean I know there was an episode fairly recently in
Fife where somebody was accessing the Emergency
Care Summary that wasn’t supposed to be, and you
know there's always that potential” (Female GP
interview 5)
As the Caldicott Guardians of all patient data held in
the GP electronic patient record, it is perhaps not sur-
prising that GPs were concerned with data security and
confidentiality. Caldicott guardians are responsible for
the safe use and handling of identifiable patient infor-
mation. This suggests GPs will require assurances about
the security of the register, including accountability and
transparency mechanisms.
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by GPs regarding ownership and consent for use of pri-
mary care data. Views were polarised with the first quote
illustrating that some GPs perceive they would have veto
as to whether patient’s data was extracted and the sec-
ond quote illustrates that GPs perceived consent was en-
tirely at the patient’s discretion. This raises interesting
questions for the research register, such as “who is the
custodian of the data?” and “can GPs veto access to pa-
tients’ records once a patient has registered?”
Impact on workload
The impact on workload was a key concern for the ma-
jority of GPs and practice managers interviewed. They
had two primary concerns in this regard, firstly the im-
pact of patient queries about register or research stud-
ies, in particular, if letters were to be sent to patients
on practice headed note paper. Secondly, GPs were
concerned they would be involved in screening their
patients to ensure they are eligible to take part in stud-
ies. Currently in the UK, GPs screen lists of patients
who meet research study eligibility criteria. Despite be-
ing concerned about workload from screening patients
they saw this as a necessary evil, to protect both pa-
tients and researchers.
“…workload attached with people contacting the
surgery for advice on “should I get involved in this
research project or not?”…but yeah potentially that’s
used up a GP appointment to do that, and that’s, that
seems a bit of a, a lost opportunity… 'cause yeah, a
patient may be inappropriate for one study but
appropriate for another study, the same patient and
not having a feel for that because often we're obviously
more aware of what’s happened in patients sort of
personally circumstances month to month and you
know a patient that was suitable for a research projects
last week may not be this week if they're, you know just
had their partner, em has died or eh, something else
going on their life or some other new medical condition
coming along,” (Male GP interview 6)
And
“… I mean the work of screening that list, I guess that in
itself might be a considerable job..” (Female GP,
interview 5)
Practice managers were concerned about the need to
ensure that information in patient records was up-to-date.
“…the telephone numbers of the patients constantly
change and it's really even hard for us to keep updated
with their telephone numbers 'cause they change theirmobiles so often…. we also have a high turnover of
patients as well, so you might find that by the time you
get in touch with somebody they’ve left or moved..”
(Female practice manager 4)
These findings raise important issues for a national
research register as to who has veto over the use of
primary care data and whether GPs will be required to
screen lists of patients for eligibility. The register will
rely on primary care data to provide up-to-date con-
tact information and to provide longitudinal data on
patients as these are the only health care records to
hold information on a patient from cradle to grave. We
expect GPs to consider whether they agree to the use
of the data held in their records on a study by study
basis taking into account the patients’ expressed
wishes to be contacted for studies in which they are
potentially eligible. These findings show GPs are an
important group of people to have on board with the
register and promotion of the research may need to ex-
tend beyond patients.
Health service researchers’ perspectives of a national
research register
The following findings are from one focus group with
10 health service researchers, data analysts and an IT
manager from across primary and secondary care
based research.
Benefit of a research register
Researchers were supportive of the initiative seeing a na-
tional research register as having the potential to over-
come their problem of accessing and recruiting patients
and offering the advantage of more rapid access to a
wider pool of patients.
“..you can only contact them through their GPs, for
specific studies, whereas this would be a much wider
opportunity.” (Male clinical researcher, research focus
group)
And
“Well, I’m sure the benefits for patients is more that
you’re giving them more opportunities to take part in
research. There are a group of patients who object to the
GP being the gate-keeper and feel that they should be
asked rather than the GP deciding whether they should
be asked is the main benefit” (Female health services
researcher, research focus group).
Although supportive of a national research register, re-
searchers raised some issues they felt needed to be
addressed to ensure the functionality of a register:
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Some researchers raised concerns GPs may be able to
block patient involvement in the register by refusing ac-
cess to patient’s personal data or by not giving permis-
sion for the data-extraction to take place from their
clinical system:
“It has to be through the GP so if their GP doesn’t want
to be involved, you can be losing a great amount of
patients that may be willing to take part in this
research and it is because their GP is gatekeeping”
(Female health service researcher, research focus
group).
And
“…you will have a two-tier system whereby you would
have presumably a very large cohort of patients who
had agreed and whose GPs had agreed to make the
data available and then perhaps a much smaller sub-
group of people who had agreed and for one reason or
another the GPs felt they didn’t want to share the
data..” (Male clinical researcher, research focus group).
This also raised the issue about whether GPs can veto
patients’ participation in the research register.
Others were concerned that only the middle classes
would register:
“Is there a danger…that you’re only going to get these
very middle class people so all the trials end up being
done on people who have not really got anything wrong
with them?” (Male health services researcher, research
focus group)
This is a common problem in research, in particular
with studies which use opt-in models. An important
issue for some studies hoping to use the register will be
the representativeness of registrants. It is therefore
intended that targeted advertising and social networking
will attract patients from a wide range of groups in
society.
Measures are required to ensure eligibility of patients
Researchers expressed concern about contacting de-
ceased patients and would like to see some measures in
place to protect against this in the national research
register:
“I take it one of the benefits we’re looking for is to
prevent what’s happened in the past, people making
contact with patients who have been deceased since and
the accuracy…..what’s the lag between the register being
updated and someone actually being approached.There’s examples over the last fifteen months were
patients were approached through various registers and
they’d died.” (Male data analyst, research focus group)
And
“If someone has said I’m happy to be contacted and
some researcher contacts him unfortunately after he’s
died, it’s not acceptable….you need to make sure that
you didn’t do it again” (Male health services researcher,
research focus group).
And
“That comes back to the idea that maybe this does
need….at least the request to participate does need to be
routed via the GP, even if it’s electronically to establish
that they’re still alive and what conditions they have
and then you approached them” (Male health services
researcher, research focus group).
GPs record when a patient is deceased and the register
can also be linked to the Scottish General Registrar Of-
fice (GRO), the research register will extract data from
GP practice systems nightly so the information used by
the research register will be the most up-to-date and the
chances of a deceased patient being identified are min-
imal. There are other reasons for which GPs screen
patient lists, such as a close family member recently
passing away.
Discussion
There was clear support for the concept of a research
register to facilitate recruitment to research studies from
patients, practitioners and researchers. Although sup-
portive, some patients and GPs require assurances about
data security and accountability. Without these assur-
ances in place researchers were concerned the register
may not be representative and/or GPs may be able to
veto patient’s participation in the register.
Scotland has a public sector health service covering
the entire population, and using a single patient identi-
fier for all health records. This offers a unique opportun-
ity, with cradle to grave records on the whole population
in a range of EHRs (primary care, hospital, dental, pre-
scribing, laboratory, screening and immunisation re-
cords). There was general agreement that these records
should be used for the public good, an assumption by
patients that at some levels this was already being done,
and no questions were asked about the technical ability
to data link, extract or search the records of those on
the register.
For the patient groups in our study the motivation for
participation in a national research register was largely
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without any expectation of direct benefit to them. Any
promotion of a national register must be careful not to
give patients false hope and to promote participant al-
truism. For those who chose to give a ‘gift’ to society it is
important to ensure their data appropriately cared for,
ensuring data confidentiality and security.
Patients would like to see a public body, operated by
public servants in control of a national research register.
This implies high levels of institutional trust for these
organisations [24]. Their lack of questioning of the data
linkage and extraction technology can be viewed as
implied trust of NHS staff, researchers and the NHS IT
infrastructure. Although, some participants sought re-
assurance about how secure and confidential their per-
sonal data would be implying levels of conditional trust.
However, lack of trust or conditional trust does not
mean distrust [25]. Unsurprisingly, there were differing
levels of trust, highlighting for some members of society,
trust in the register will not be voluntarily given and ac-
countability information, reassurance and evidence of
successful operations will be required. For those groups
who give their trust this should be highly valued.
Patients favoured an approach which focuses on the
social good and public nature of this research, leading
participants, by a majority, to reject the notion of invest-
ment by pharmaceutical companies in the register infra-
structure. Whereas views were polarised over use of the
register for commercial gain by making it available to re-
search studies funded by pharmaceutical companies.
This issue may have been different in other healthcare
systems where private providers predominate. However,
the issue of ownership and control of personal data
when it is to be exploited for commercial gain has arisen
in many different healthcare systems [26,27]. Legal deci-
sions on this vary, but for a voluntary register based on
trust to be successful, complete transparency will be re-
quired. When current ethical and legal restrictions were
described to patients in our study this seemed to re-
assure people, however more detailed exploration of
what is likely to be acceptable to the wider Scottish pub-
lic is required. The development of a national register
needs to be within an accepted legal, ethical and govern-
ance framework.
As the Caldicott Guardians and custodians of patient’s
cradle-to-grave health record it is advantageous if a na-
tional research register has the backing of general practi-
tioners. Researchers participating in this study were
concerned GPs would be able to veto a patient’s consent
to take part in the register. GPs are not in a position to
veto patients consent to take part in a national research
register, but GPs have total control over access to data
held in their clinical systems, and will be able, to some
extent, to influence volunteer uptake. It is likely GPs willbe able to influence uptake or access to data at three
stages of the research register process: 1) registration; 2)
data access; and 3) utilisation. As a result it is important
to address the concerns raised by GPs about the impact
on their workload and provide reassurances regarding
accountability and market a national research register to
health professionals as well as patients.
Patients desired a range of media to promote a na-
tional register, emphasising this is a venture which is not
suited to a ‘one size fits all’ approach. Given the diversity
of research studies which are likely to use the research
register and levels of contribution required from each,
the register must be able to attract a number of regis-
trants from different societal groups to be able to offer a
comprehensive service, which caters to the needs of all
research studies.
Strengths and limitations of the study
These findings have highlighted a number of important
issues for the key stakeholders in a national research
register. A strength of this research is its timing,
allowing these findings to inform the design and devel-
opment of a national research register and contribute to
a wider debate and national programme of research and
development of EHRs [28].
This study was only conducted within two health
boards in Scotland to gain an understanding if a re-
search register was acceptable to patients, health profes-
sionals and researchers. Unfortunately, we had a low
response rate to invitations to participate in the patient
focus groups. This may be a reflection of a lack of inter-
est or may be due to the fact no reminder letters were
sent and patients were only invited once. The views of
policy commissioners were not explored. As in any
study, we had to make choices in our study design to
balance ideal recruitment figures with feasibility and re-
source constraints. Only one focus group was held with
health services researchers and those recruited had ex-
tensive experience in data-linkage and large database
studies. As a result their views may not be representative
of all health services researchers working with a range of
methodologies. Likewise, the GPs and practice managers
had previously taken part in research and their views
may not be representative of their professional groups.
Although two thirds of Scottish general practices are re-
search active (Alison Hinds, Scottish Primary Care Re-
search Network, personal communication). There was
clear enthusiasm among the patients we spoke to, but
these people were to some extent self-selecting and
younger people in particular were under-represented.
Previous research has suggested that younger people are
concerned about allowing access to their personal infor-
mation [29]. It is not clear if the general public would be
so altruistic; many of these people were recruited via
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the NHS and public institutions. However, we believe
seventeen interviews with professionals, seven focus
groups with patients and one focus group with health
services researchers provided a sufficient level of evi-
dence for an explorative study of this nature.Comparison with other studies
Although a national research register is a novel con-
cept the acceptability of disease specific registries has
been shown [6,7,30]. The acceptability and knowledge
of ethical and legal governance regulations was im-
portant, concern about privacy, security and consent
could stifle a national research register [31,32] and
studies which seek representative samples [33]. As
others have found, patients had concerns about the
frequency of requests to participate, the extent of com-
mitment required, and who the sponsors potentially
may be within disease specific registers [33]. Patients
placed high levels of trust in GPs and the NHS,
confirming other studies [34]. For patients, their trust
was tempered by a concern to know more about the
practicalities of the process. Patients and health practi-
tioners wanted greater clarity on nature of recruitment
and data management processes as a basis for this
trust, mirroring the findings of others [30,35,36].
Recruitment to clinical studies is a major concern for
all healthcare researchers [5]. There is also evidence that
many people would like to participate in medical re-
search if they knew of suitable projects. This has been
demonstrated in the United States by Mediguard and
Research Match [10,11].Implications for future research
These findings have raised a number of important design
and operationalization issues but also highlighted issues
which will require further public engagement.
This study did not explore the views of patients to-
wards the secondary use of their data. Further re-
search is required to establish how patients perceive
their consent to a national research register and asso-
ciated research studies. Establishing patient views to-
wards the secondary use of their personal data was
beyond the scope of this study however, the concern
by patients about the security and confidentiality of
their data raises this as an issue for further consider-
ation [37].
Participants in the patient focus groups rarely men-
tioned concerns about sensitive data such as sexual or
mental health unless probed. Researchers were concer-
ned about contacting deceased patients. More detailed
exploration about the handling of sensitive information
within a national research register is required.Since this research study was completed a ministerial
announcement has been made by the Scottish Health
Minister that the register has been adopted by NHS
Research Scotland (NRS) and branded SHARE (Scot-
tish Health Research Register) [18,38]. The national re-
searcher register will operate through the existing
infrastructure and operating procedures of the Scottish
Health Informatics Programme [18]. There has been
extensive development and pilot work carried out by
the Health Informatics Centre at the University of
Dundee since the completion of this work and the
SHARE process has been influenced by these findings.
Conclusions
Providing suitable safeguards are in place, patients,
health service staff and researchers have a favourable
view of the potential benefits of a national register
held within the public sector to identify people who
are potentially eligible and willing to participate in
health related research. UK Government policies are
encouraging greater use of the data in EHRs to en-
courage more rapid progress with clinical research,
though consent cannot be assumed [39,40]. The Nuffield
Council on Bioethics Working Group has recommended
that the patients’ right to opt-out of a database sys-
tem at any time should be recognised; that the pa-
tients should be asked explicitly to consent to the
sharing of their records outside of the primary care
environment; and that organisations responsible for
sharing EHRs engage more effectively with patients
to identify what forms of data sharing are accepted as
legitimate [41].
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